New Matter: Inside the Minds of SLAS Scientists

Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity

April 11, 2020 SLAS Episode 18
New Matter: Inside the Minds of SLAS Scientists
Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity
Chapters
New Matter: Inside the Minds of SLAS Scientists
Iscaffpharma Highlights Technology & Innovation AveNEW Opportunity
Apr 11, 2020 Episode 18
SLAS

Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.

Show Notes

Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.